NF-κB nuclear translocation/activation, as a result of its release from the complex with phosphorylated inhibitor IκB after the proteasome-dependent degradation of IκB [58], required both AKT and IKKβ activities in glioblastoma cells. The gene discussed is NFKB1; the disease is glioblastoma.